-
EXTERNAL CONTROL ARM FEASIBILITY ACROSS EXTERNAL DATA SOURCES IN ONCOLOGY: METHODOLOGICAL AND REGULATORY SCIENCE CONSIDERATIONS
Mar 18, 2026, 21:38 PM -
IMPLEMENTATION OF MANAGED-ENTRY AGREEMENTS IN HTA SUBMISSIONS: TYPES, USE-CASES, AND OPERATIONAL CONSIDERATIONS
Mar 18, 2026, 21:38 PM -
EPIDEMIOLOGY AND CLINICAL PROGRESSION OF SYSTEMIC LUPUS ERYTHEMATOSUS AND LUPUS NEPHRITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM: A REAL-WORLD STUDY (2012-2024)
Mar 18, 2026, 21:38 PM -
BUDGET IMPACT MODEL (BIM) OF BELANTAMAB MAFODOTIN (BELAMAF) IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE (BVD) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) IN THE UNITED STATES (US)
Mar 18, 2026, 21:38 PM -
CLAIMS-BASED ALGORITHM OPTIONS TO IDENTIFY REDUCED LEFT VENTRICULAR EJECTION FRACTION PATIENTS WITH MITRAL OR TRICUSPID VALVE REGURGITATION AND HEART FAILURE
Mar 18, 2026, 21:38 PM -
PERFORMANCE METRICS FOR AI IN SLRS: A RAPID LITERATURE REVIEW OF GUIDELINE RECOMMENDATIONS FOR ACCEPTABLE THRESHOLDS
Mar 18, 2026, 21:38 PM -
TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION, AND DIRECT MEDICAL COSTS OF CHRONIC URTICARIA IN CHINA: A REAL-WORLD STUDY
Mar 18, 2026, 21:38 PM -
MPACT OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AGONISTS TO TREAT OBESITY ON NON-GLP-1 COSTS AMONG COMMERCIALLY INSURED MEMBERS WITHOUT DIABETES: A THREE-YEAR RETROSPECTIVE ANALYSIS
Mar 18, 2026, 21:38 PM -
LUNG CANCER RELATED SPILLOVER EFFECT ON FAMILY MEMBER’S HEALTH-RELATED QUALITY OF LIFE: A US-BASED EMPIRICAL ANALYSIS
Mar 18, 2026, 21:38 PM -
REAL-WORLD TREATMENT PATTERNS AND MACHINE LEARNING PREDICTORS OF LATER-LINE THERAPY IN METASTATIC COLORECTAL CANCER
Mar 18, 2026, 21:38 PM -
COMPARISON OF THE PERFORMANCE OF PATIENT-MEDIATED MEDICAL RECORD RETRIEVAL AND TOKENIZATION-BASED LINKAGE TO GENERATE COMPLETE AND LONGITUDINAL REAL-WORLD DATA
Mar 18, 2026, 21:38 PM -
LONG-TERM PROJECTIONS OF PEDIATRIC IMMUNE THROMBOCYTOPENIA BURDEN IN THE UNITED STATES: EPIDEMIOLOGIC INSIGHTS FROM 2025 TO 2050
Mar 18, 2026, 21:38 PM -
REVIEW OF CELL THERAPY ACCESS LANDSCAPE
Mar 18, 2026, 21:38 PM -
ALIGNMENT OF HEALTH PLAN REAUTHORIZATION CRITERIA WITH CLINICAL TRIAL ENDPOINTS FOR NEUROMUSCULAR DISEASE THERAPIES
Mar 18, 2026, 21:38 PM -
IMPORTANCE OF ORAL DRUG PRODUCT CHARACTERISTICS TO PATIENTS AND IMPLICATIONS OF CHARACTERISTIC CHANGES FOR MISSED DOSES AND INFORMATION SEEKING
Mar 18, 2026, 21:38 PM -
A REAL-WORLD ANALYSIS OF THE COMPLEX TREATMENT PATTERNS OF LONG-TERM COPD INHALERS
Mar 18, 2026, 21:38 PM -
QUALITY ASSESSMENT IN A SYSTEMATIC LITERATURE REVIEW USING AN ARTIFICIAL INTELLIGENCE MODEL
Mar 18, 2026, 21:38 PM -
CLINICAL AND ECONOMIC BURDEN IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
EPIDEMIOLOGICAL CHARACTERISTICS OF DIABETIC KIDNEY DISEASE IN CHINESE PATIENTS WITH TYPE 2 DIABETES VISITING A TERTIARY CARE HOSPITAL: A RETROSPECTIVE ANALYSIS
Mar 18, 2026, 21:38 PM -
INFLATION REDUCTION ACT “PILL PENALTY” AND SMALL-MOLECULE INNOVATION: SIGNALS FROM INVESTMENT, PIPELINES, AND POST-APPROVAL RESEARCH?
Mar 18, 2026, 21:38 PM
